Prospective Cohort Study : Evaluation of Prognosis Criteria for Walking Independently Recovery After Stroke.

October 27, 2022 updated by: University Hospital, Caen

Prognosis Criteria for Walking Independently Recovery After Stroke : Evaluation of the TWIST Algorithm

Based on a 2017 US study that developed an algorithm for predicting independent walking recovery after stroke, we propose a prospective study to assess the validity and applicability of this algorithm in the majority of stroke patients with walking dependence and to confirm its performance.

This study will therefore include adult patients, hospitalised in the Neurology Department of Caen University Hospital, and presenting a dependence on walking according to the FAC (Functional Ambulation Categories) scale in the first week after stroke.

Treated by M. Pierre-Alexis Rousseau (medical intern for Physical and Rehabilitation Medicine), under the direction of Dr. Alexis Ruet, and in collaboration with the physiotherapists of the Neurology Department (Delphine Lebreton and Daphne Scelles), this study is planned to include patients in the initial phase of the stroke, and to continue to follow up the patients until 6 months after their inclusion.

The aim of this work is to evaluate the performance of the TWIST algorithm in predicting walking recovery after stroke according to trunk control (using the Trunk Control Test) and hip extension strength (using the Medical Research Council score), and to analyse other factors that may potentially influence walking recovery (such as visual field amputation, neglect, ataxia, depression, undernutrition).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The ability to walk independently is the most common goal of rehabilitation after a stroke. Whether a patient can walk independently influences decisions about the type and duration of rehabilitation and the proposed destination at discharge from acute care.

The interest of the proposed research is to replicate an American landmark study (The TWIST Algorithm Predicts Time to Walking Independently After Stroke, Smith et al.) published in Neurorehabilitation and Neural Repair in 2017, which developed an algorithm to predict recovery of independent walking after stroke, based on clinical assessment of trunk control by the Trunk Control Test (TCT) and Medical Research Council (MRC) motor strength of hip extension.

The performance of the algorithm in predicting return to walking at 6 and 12 weeks was good (< 6 weeks: Positive Predictive Value = 91%, Negative Predictive Value = 100% // < 12 weeks: Positive Predictive Value = 100%, Negative Predictive Value = 97%), but requires confirmation given the small number of patients included in the study (N = 41).

The originality of the planned research is to try to include and analyse more patients than the original study, to study other factors that may influence recovery, and to continue the follow-up up to 6 months, which wasn't done in the original study.

The expected results would allow the TWIST algorithm to be confirmed in order to better predict walking recovery independently, which could guide rehabilitation and give patients an estimate of their progress towards walking recovery.

The potential benefits for patients would be to maintain motivation for rehabilitation, and to have an impact on the medico-socio-economic level (notably by avoiding investing resources in unlikely objectives).

There are no foreseeable risks, a priori.

If the results are consistent with those of the original study, it may be possible to consider the application of the TWIST algorithm to routine practice for any first stroke causing walking dependence.

Based on the results of the original study, the patients included will be categorised according to their Truck Control Test (TCT) score and their MRC score for hip extension of the deficient limb :

  • TCT score > 40 = walking before 6 weeks,
  • TCT < 40 + MRC ≥ 3 = walking before 12 weeks,
  • TCT < 40 + MRC < 3 = dependent on walking after 12 weeks.

For all included patients: PHQ-9 depression scale and body weight at 6 weeks post-stroke, by telephone.

For patients categorised as " walking before 6 weeks " :

  • Call and assessment of FAC scale at 6 weeks,
  • If walking (FAC ≥ 4), end of follow-up,
  • If not, continuation of follow-up with call at 12 weeks.

For patients categorised as " walking before 12 weeks " :

  • Call and assessment of FAC scale at 6 and 12 weeks,
  • If walking, end of follow-up,
  • If not, continue follow-up with call at 6 months.

For patients categorised as " dependent on walking after 12 weeks " :

- Call and assessment of FAC scale at 6 weeks, 12 weeks and 6 months.

Study Type

Observational

Enrollment (Anticipated)

72

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Normandie
      • Caen, Normandie, France, 14000
        • Recruiting
        • University Hospital of Caen Normandie
        • Contact:
        • Contact:
        • Principal Investigator:
          • Pierre Alexis Rousseau
        • Sub-Investigator:
          • Delphine Lebreton

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult patients ( ≥ 18 years) hospitalised in the Neurology Department of Caen University Hospital who present stroke with walking dependance (FAC scale score < 4)

Description

Inclusion Criteria:

  • Adult patients ( ≥ 18 years) hospitalised in the Neurology Department of Caen University Hospital
  • FAC scale score < 4 (walking dependent) in the first week after stroke
  • Oral and written comprehension of the French language
  • Affiliation to a social security scheme

Exclusion Criteria:

  • Patient dependent on walking (FAC < 4) before stroke
  • Short-term (< 3 months) life-threatening condition
  • Communication impairment (severe aphasia, impaired consciousness) and/or cognitive impairment preventing informed consent and/or rehabilitation
  • Opposition of the patient
  • Patient under legal protection (guardianship or curators)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adult patients hospitalised in the Neurology Department of Caen University Hospital
Measurement of walking dependency according to the FAC scale (in the first week after stroke by physiotherapists, at 6 weeks, 12 weeks and 6 months by telephone).

Measurement of walking dependency according to the FAC scale :

  • in the first week after stroke (in neurology by physiotherapists),
  • then at 6 weeks, 12 weeks and 6 months (by telephone).

Trunk Control Test score (in the first week after stroke, by physiotherapists).

MRC score of hip extension and hip flexion, knee flexion/extension, ankle plantar and dorsal flexion (in the first week after stroke, by physiotherapists).

PHQ-9 depression scale (at 6 weeks by phone).

Denutrition (weight loss between neurology weight and 6-week weight, BMI +/- albumin).

Other intercurrent medical problems (at each telephone interview).

Other Names:
  • TCT (Trunk Control Test) score
  • MRC (Medical Research Council) score
  • PHQ-9 (Patient Health Questionnaire-9) depression scale

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Ambulation Categories (FAC)
Time Frame: Change from Baseline (first week after stroke) FAC score at 6 weeks after stroke
Functional Ambulation Categories (FAC) to classify the patient's walking as dependent or non-dependent.
Change from Baseline (first week after stroke) FAC score at 6 weeks after stroke
Functional Ambulation Categories (FAC)
Time Frame: Change from Baseline (1 week after stroke) FAC score at 12 weeks after stroke
Functional Ambulation Categories (FAC) to classify the patient's walking as dependent or non-dependent.
Change from Baseline (1 week after stroke) FAC score at 12 weeks after stroke

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: At first week after stroke
Demographic characteristic
At first week after stroke
Gender
Time Frame: At first week after stroke
Demographic characteristic
At first week after stroke
National Institutes of Health Stroke Scale (NIHSS) score
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
"Visual field" item of the National Institutes of Health Stroke Scale (NIHSS)score
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
"Extinction and neglect" item of the National Institutes of Health Stroke Scale (NIHSS)score
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
"Ataxia" item of the National Institutes of Health Stroke Scale (NIHSS)score
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Medical Research Council (MRC) score for hip extension
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Medical Research Council (MRC)score for hip flexion
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Medical Research Council (MRC)score for knee extension
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Medical Research Council (MRC)score for knee flexion
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Medical Research Council (MRC)score for ankle plantar flexion
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Medical Research Council (MRC)score for ankle dorsal flexion
Time Frame: At first week after stroke
Clinical characteristic
At first week after stroke
Patient Health Questionnaire (PHQ-9) depression scale
Time Frame: At 6 weeks after stroke
Description of the patient's mental health status at the end of the PHQ-9 depression questionnaire
At 6 weeks after stroke
Undernutrition
Time Frame: At 6 weeks after stroke
Search for weight loss between the weight in neurology and the weight at 6 weeks, Body Mass Index +/- albumin
At 6 weeks after stroke

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Alexis Ruet, Physical Medicine and Rehabilitation Department in the University Hospital of Caen
  • Principal Investigator: Pierre Alexis Rousseau, Physical Medicine and Rehabilitation Department in the University Hospital of Caen
  • Study Chair: Clemence Tomadesso, Clinical Research Unit of University Hospital of Caen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2022

Primary Completion (Anticipated)

March 31, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

September 30, 2022

First Submitted That Met QC Criteria

October 5, 2022

First Posted (Actual)

October 10, 2022

Study Record Updates

Last Update Posted (Actual)

October 31, 2022

Last Update Submitted That Met QC Criteria

October 27, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on FAC scale

Subscribe